vadimezan has been researched along with Stomach Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gehmert, S; Geissler, EK; Hackl, C; Jung, EM; Lang, SA; Moser, C; Pfister, K; Schlitt, HJ; Schnitzbauer, AA; Stroszczynski, C | 1 |
1 other study(ies) available for vadimezan and Stomach Neoplasms
Article | Year |
---|---|
Contrast-enhanced ultrasound (CEUS) detects effects of vascular disrupting therapy in an experimental model of gastric cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Contrast Media; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Random Allocation; Stomach Neoplasms; Ultrasonography, Interventional; Xanthones; Xenograft Model Antitumor Assays | 2014 |